ImmuCell Corporation Financing Cash Flow
ImmuCell Corporation (ICCC) reported Financing Cash Flow of -$637.56 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- ImmuCell Corporation net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$237.56K.
- ImmuCell Corporation net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$400.00K.
- ImmuCell Corporation net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$394.60K, a 365.07% decline year-over-year.
- ImmuCell Corporation net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$337.69K, a 110.51% decline year-over-year.
- ImmuCell Corporation net cash provided by (used in) financing activities for fiscal 2025 was -$1.21M, a 142.06% decline from fiscal 2024.
- ImmuCell Corporation net cash provided by (used in) financing activities for fiscal 2024 was $2.88M, a 64.60% increase from fiscal 2023.
- ImmuCell Corporation net cash provided by (used in) financing activities for fiscal 2023 was $1.75M, a 57.19% increase from fiscal 2022.
- ImmuCell Corporation net cash provided by (used in) financing activities for fiscal 2022 was $1.11M, a 71.27% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$237.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$637.56K 10-Q · filed 2026-08-13 | -$1.03M derived: sum of 3 quarters · filed 2026-08-13 | -$1.37M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$400.00K 10-Q · filed 2026-05-14 | -$794.60K derived: sum of 2 quarters · filed 2026-05-14 | -$1.13M derived: sum of 3 quarters · filed 2026-05-14 | -$1.21M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$394.60K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$732.29K derived: sum of 2 quarters · filed 2026-03-30 | -$808.74K derived: sum of 3 quarters · filed 2026-08-13 | -$1.21M 10-K · filed 2026-03-30 |
| 2025-09-30 | -$337.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$414.14K derived: sum of 2 quarters · filed 2026-08-13 | -$817.78K 10-Q · filed 2025-11-13 | -$668.92K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$76.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$480.10K 10-Q · filed 2026-08-13 | -$331.23K derived: sum of 3 quarters · filed 2026-08-13 | $2.88M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$403.65K 10-Q · filed 2026-05-14 | -$254.78K derived: sum of 2 quarters · filed 2026-05-14 | $2.96M derived: sum of 3 quarters · filed 2026-05-14 | $2.85M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $148.87K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $3.36M derived: sum of 2 quarters · filed 2026-03-30 | $3.25M derived: sum of 3 quarters · filed 2026-03-30 | $2.88M 10-K · filed 2026-03-30 |
| 2024-09-30 | $3.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $3.10M derived: sum of 2 quarters · filed 2025-11-13 | $2.73M 10-Q · filed 2025-11-13 | $2.41M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$111.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$478.14K 10-Q · filed 2025-08-14 | -$799.58K derived: sum of 3 quarters · filed 2025-08-14 | $776.59K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$366.54K 10-Q · filed 2025-05-14 | -$687.98K derived: sum of 2 quarters · filed 2025-05-14 | $888.19K derived: sum of 3 quarters · filed 2025-05-14 | $636.29K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$321.43K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $1.25M derived: sum of 2 quarters · filed 2025-03-28 | $1.00M derived: sum of 3 quarters · filed 2025-03-28 | $1.75M 10-K · filed 2025-03-28 |
| 2023-09-30 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $1.32M derived: sum of 2 quarters · filed 2024-11-13 | $2.07M 10-Q · filed 2024-11-13 | $1.82M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | -$251.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $496.72K 10-Q · filed 2024-08-13 | $248.51K derived: sum of 3 quarters · filed 2024-08-13 | $25.41K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $748.62K 10-Q · filed 2024-05-14 | $500.42K derived: sum of 2 quarters · filed 2024-05-14 | $277.31K derived: sum of 3 quarters · filed 2024-05-14 | $73.23K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$248.21K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$471.31K derived: sum of 2 quarters · filed 2024-04-01 | -$675.39K derived: sum of 3 quarters · filed 2024-04-01 | $1.11M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$223.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$427.18K derived: sum of 2 quarters · filed 2023-11-13 | $1.36M 10-Q · filed 2023-11-13 | $1.17M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$204.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.59M 10-Q · filed 2023-08-10 | $1.39M derived: sum of 3 quarters · filed 2023-08-10 | $1.60M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $1.79M 10-Q · filed 2023-05-11 | $1.59M derived: sum of 2 quarters · filed 2023-05-11 | $1.80M derived: sum of 3 quarters · filed 2023-05-11 | $5.84M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$194.91K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $12.74K derived: sum of 2 quarters · filed 2023-03-29 | $4.06M derived: sum of 3 quarters · filed 2023-03-29 | $3.88M 10-K · filed 2023-03-29 |
| 2021-09-30 | $207.64K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $4.25M derived: sum of 2 quarters · filed 2022-11-21 | $4.07M 10-Q · filed 2022-11-21 | $4.79M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $4.04M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-11-21 | $3.87M 10-Q/A · filed 2022-11-21 | $4.58M derived: sum of 3 quarters · filed 2022-11-21 | $4.44M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | -$176.43K 10-Q/A · filed 2022-11-21 | $540.82K derived: sum of 2 quarters · filed 2022-11-21 | $397.64K derived: sum of 3 quarters · filed 2022-11-21 | $1.69M derived: sum of 4 quarters · filed 2022-11-21 |
| 2020-12-31 | $717.24K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $574.07K derived: sum of 2 quarters · filed 2022-03-30 | $1.87M derived: sum of 3 quarters · filed 2022-03-30 | $1.91M 10-K · filed 2022-03-30 |
| 2020-09-30 | -$143.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.15M derived: sum of 2 quarters · filed 2021-11-15 | $1.19M 10-Q · filed 2021-11-15 | $976.55K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.34M 10-Q · filed 2021-08-12 | $1.12M derived: sum of 3 quarters · filed 2021-08-12 | $904.55K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $41.13K 10-Q · filed 2021-05-13 | -$176.08K derived: sum of 2 quarters · filed 2021-05-13 | -$391.25K derived: sum of 3 quarters · filed 2021-05-13 | -$605.91K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$217.22K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$432.38K derived: sum of 2 quarters · filed 2021-03-30 | -$647.04K derived: sum of 3 quarters · filed 2021-03-30 | $6.94M 10-K · filed 2021-03-30 |
| 2019-09-30 | -$215.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$429.83K derived: sum of 2 quarters · filed 2020-11-12 | $7.16M 10-Q · filed 2020-11-12 | $7.52M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$214.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $7.37M 10-Q · filed 2020-08-12 | $7.74M derived: sum of 3 quarters · filed 2020-08-12 | $8.10M derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $7.59M 10-Q · filed 2020-05-13 | $7.95M derived: sum of 2 quarters · filed 2020-05-13 | $8.31M derived: sum of 3 quarters · filed 2020-05-13 | $8.25M derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $364.88K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $723.88K derived: sum of 2 quarters · filed 2020-03-27 | $658.64K derived: sum of 3 quarters · filed 2020-03-27 | $889.62K 10-K · filed 2020-03-27 |
| 2018-09-30 | $359.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $293.76K derived: sum of 2 quarters · filed 2019-11-12 | $524.73K 10-Q · filed 2019-11-12 | $6.37M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | -$65.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $165.73K 10-Q · filed 2019-08-12 | $6.01M derived: sum of 3 quarters · filed 2019-08-12 | $8.70M derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $230.97K 10-Q · filed 2019-05-13 | $6.07M derived: sum of 2 quarters · filed 2019-05-13 | $8.77M derived: sum of 3 quarters · filed 2019-05-13 | $9.72M derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $5.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $8.54M derived: sum of 2 quarters · filed 2019-03-22 | $9.49M derived: sum of 3 quarters · filed 2019-03-22 | $9.75M 10-K · filed 2019-03-22 |
| 2017-09-30 | $2.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $3.65M derived: sum of 2 quarters · filed 2018-11-13 | $3.90M 10-Q · filed 2018-11-13 | $7.03M derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $953.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $1.21M 10-Q · filed 2018-08-13 | $4.33M derived: sum of 3 quarters · filed 2018-08-13 | $4.33M derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $255.92K 10-Q · filed 2018-05-14 | $3.38M derived: sum of 2 quarters · filed 2018-05-14 | $3.38M derived: sum of 3 quarters · filed 2018-05-14 | $3.34M derived: sum of 4 quarters · filed 2018-05-14 |
| 2016-12-31 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $3.12M derived: sum of 2 quarters · filed 2018-03-29 | $3.08M derived: sum of 3 quarters · filed 2018-03-29 | $8.32M 10-K · filed 2018-03-29 |
| 2016-09-30 | -$4.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$45.00K derived: sum of 2 quarters · filed 2017-08-14 | $5.20M 10-Q · filed 2016-11-10 | $5.16M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-06-30 | -$40.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $5.20M 10-Q · filed 2017-08-14 | $5.17M derived: sum of 3 quarters · filed 2017-08-14 | $7.68M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | $5.24M 10-Q · filed 2017-05-11 | $5.21M derived: sum of 2 quarters · filed 2017-05-11 | $7.72M derived: sum of 3 quarters · filed 2017-05-11 | $7.73M derived: sum of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | -$34.78K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $2.48M derived: sum of 2 quarters · filed 2017-03-30 | $2.49M derived: sum of 3 quarters · filed 2017-03-30 | $2.44M 10-K · filed 2017-03-30 |
| 2015-09-30 | $2.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $2.52M derived: sum of 2 quarters · filed 2016-11-10 | $2.48M 10-Q · filed 2016-11-10 | $2.43M derived: sum of 4 quarters · filed 2016-11-10 |
| 2015-06-30 | $4.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | -$38.87K 10-Q · filed 2016-08-11 | -$87.53K derived: sum of 3 quarters · filed 2016-08-11 | -$135.28K derived: sum of 4 quarters · filed 2016-08-11 |
| 2015-03-31 | -$43.81K 10-Q · filed 2016-05-11 | -$92.47K derived: sum of 2 quarters · filed 2016-05-11 | -$140.22K derived: sum of 3 quarters · filed 2016-05-11 | -$187.33K derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | -$48.67K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$96.42K derived: sum of 2 quarters · filed 2016-03-25 | -$143.52K derived: sum of 3 quarters · filed 2016-03-25 | -$187.16K 10-K · filed 2016-03-25 |
| 2014-09-30 | -$47.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$94.86K derived: sum of 2 quarters · filed 2015-11-12 | -$138.50K 10-Q · filed 2015-11-12 | -$162.75K derived: sum of 4 quarters · filed 2016-03-25 |
| 2014-06-30 | -$47.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$90.75K 10-Q · filed 2015-08-13 | -$115.00K derived: sum of 3 quarters · filed 2016-03-25 | -$160.51K derived: sum of 4 quarters · filed 2016-03-25 |
| 2014-03-31 | -$43.64K 10-Q · filed 2015-05-12 | -$67.89K derived: sum of 2 quarters · filed 2016-03-25 | -$113.40K derived: sum of 3 quarters · filed 2016-03-25 | -$158.30K derived: sum of 4 quarters · filed 2016-03-25 |
| 2013-12-31 | -$24.25K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | -$69.76K derived: sum of 2 quarters · filed 2016-03-25 | -$114.66K derived: sum of 3 quarters · filed 2016-03-25 | -$159.30K 10-K · filed 2016-03-25 |
| 2013-09-30 | -$45.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$90.41K derived: sum of 2 quarters · filed 2014-11-12 | -$135.05K 10-Q · filed 2014-11-12 | -$178.87K derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-06-30 | -$44.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | -$89.53K 10-Q · filed 2014-08-13 | -$133.36K derived: sum of 3 quarters · filed 2015-03-26 | -$176.72K derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-03-31 | -$44.63K 10-Q · filed 2014-05-14 | -$88.46K derived: sum of 2 quarters · filed 2015-03-26 | -$131.82K derived: sum of 3 quarters · filed 2015-03-26 | -$174.58K derived: sum of 4 quarters · filed 2015-03-26 |
| 2012-12-31 | -$43.82K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | -$87.18K derived: sum of 2 quarters · filed 2015-03-26 | -$129.95K derived: sum of 3 quarters · filed 2015-03-26 | -$114.79K 10-K · filed 2015-03-26 |
| 2012-09-30 | -$43.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$86.13K derived: sum of 2 quarters · filed 2013-11-13 | -$70.97K 10-Q · filed 2013-11-13 | -$95.04K derived: sum of 4 quarters · filed 2013-11-13 |
| 2012-06-30 | -$42.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$27.61K 10-Q · filed 2013-08-13 | -$51.68K derived: sum of 3 quarters · filed 2013-08-13 | $10.95K derived: sum of 4 quarters · filed 2013-08-13 |
| 2012-03-31 | $15.16K 10-Q · filed 2013-05-14 | -$8.91K derived: sum of 2 quarters · filed 2013-05-14 | $53.71K derived: sum of 3 quarters · filed 2013-05-14 | $50.67K derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | -$24.07K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $38.55K derived: sum of 2 quarters · filed 2013-03-28 | $35.52K derived: sum of 3 quarters · filed 2013-03-28 | $614.58K 10-K · filed 2013-03-28 |
| 2011-09-30 | $62.63K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | $59.59K derived: sum of 2 quarters · filed 2012-11-13 | $638.65K 10-Q · filed 2012-11-13 | $634.26K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-06-30 | -$3.04K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-07 | $576.03K 10-Q/A · filed 2012-09-07 | $571.63K derived: sum of 3 quarters · filed 2013-03-28 | $1.54M derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-03-31 | $579.07K 10-Q · filed 2012-05-14 | $574.67K derived: sum of 2 quarters · filed 2013-03-28 | $1.54M derived: sum of 3 quarters · filed 2013-03-28 | |
| 2010-12-31 | -$4.39K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $965.65K derived: sum of 2 quarters · filed 2013-03-28 | $965.65K 10-K · filed 2013-03-28 | |
| 2010-09-30 | $970.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $970.05K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-15 | |||
| 2009-12-31 | $100.67K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |